期刊文献+

理阿诺碱对雷帕霉素诱导的内皮生长晕细胞功能抑制的保护作用

Effects of ryanodine on rapamycin-induced inhibition of endothelial outgrowth cells
下载PDF
导出
摘要 目的 探讨理阿诺碱对雷帕霉素诱导的内皮生长晕细胞(EOCs)功能抑制的影响.方法 密度梯度离心法分离脐血单个核细胞,培养并扩增EOCs,免疫组化法、荧光染色法鉴定其内皮细胞特性.分别加雷帕霉素、理阿诺碱、理阿诺碱预处理1h再加雷帕霉素,与EOCs作用24h,CCK8检测细胞增殖能力,Transwell小室检测细胞迁移能力,并在倒置显微镜下检测细胞的黏附能力.结果 雷帕霉素抑制EOCs的增殖、迁移、黏附能力(P<0.05).理阿诺碱预处理1h能改善雷帕霉素对EOCs的增殖、迁移、黏附的抑制作用(P<0.05),理阿诺碱单独作用对EOCs的增殖、迁移、黏附无影响(P >0.05).结论 雷帕霉素抑制EOCs的增殖、迁移、黏附能力 理阿诺碱可以改善雷帕霉素诱导的对体外培养的EOCs增殖、迁移、黏附的抑制作用. Objective To investigate the effects of Ryanodine on Rapamycin-induced inhabition in endothelial outgrowth cells (EOCs). Methods The mononuclear cells were harvested from umbilical cord blood by Ficoll density gradient centrifugation, which are then induced into EOCs and expanded in vitro. The endothelial characteristics of EOCs were identified by immunostaining and fluorescent staining. The EOCs were pretreated with or without Ryanodine for lh, and then treated with or without Rapamycin for 24h. Cell proliferation was evaluated by CCK8 and migration was examined by Transwell. Adhesion of E^Cs was measured under the inverted microscopy by counting adherent cells after ceil replating. Results Rapamycin down-regulated proliferation, migration and adhesion abilities of EOCs (P〈0.05). Pretreated with Ryanodine enhanced the inhibitive effects on EOCs proliferation, migration and adhesion induced by Rapamycin (P〈0.05). Treated with Ryanodine alone did not affect proliferative, migratory, adhesive ability of EOCs compared to control group (P 〉0.05). Conclusion Ryanodine can enhance rapamycin-induced inhibitive effects on proliferative, migratory, adhesive abilities of EOCs.
出处 《浙江医学》 CAS 2011年第4期505-507,532,共4页 Zhejiang Medical Journal
基金 基金项目:温州市科技局科技项目(H20080024、H20100009)
关键词 雷帕霉素 理阿诺碱 内皮生长晕细胞 再内皮化 血管狭窄 Rapamycin Ryanodine Endothelial outgrowth cell Reendothelialization Angiostenosis
  • 相关文献

参考文献14

  • 1Lin Y,Weisdorf D J,Solovey A,et al.Origins of circulating endothelial cells and endothelial outgrowth from blood[J].J Clin Invest,2000,105(1):71-77.
  • 2Hur J,Yoon C H,Kim H S,et al.Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis[J].Arterioscler Thromb Vasc Biol,2004,24 (2):288-293.
  • 3Patel S D,Waltham M,Wadoodi A,et al.The role of endothelial cells and their progenitors in intimal hyperplasia[J].Ther Adv Cardiovasc Dis,2010,4(2):129-141.
  • 4Miriuka S G,Rao V,Peterson M,et al.mTOR inhibition induces endothelial progenitor cell death[J].Am J Transplant,2006,6(9):2069-2079.
  • 5Ingram D A,Mead L E,Tanaka H,et al.Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood[J].Blood,2004,104(9):2752-2760.
  • 6林以诺,张怀勤,虞慧君,杨德业,黄晓燕.罗格列酮对ADMA氧化应激损伤内皮生长晕细胞的影响[J].中国病理生理杂志,2008,24(11):2126-2131. 被引量:4
  • 7Wang S H,Lin S J,Chen Y H,et al.Late outgrowth endothelial cells derived from Wharton Jelly in human umbilical cord reduce neointimal formation after vascular injury:involvement of pigment epithelium-derived factor[J].Arterioscler Thromb Vasc Bid,2009,29 (6):816-822.
  • 8Kong D,Melo L G,Gnecchi M,et al.Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries[J].Circulation,2004,110(14):2039-2046.
  • 9Hristov M,Weber C.Endothelial progenitor cells in vascular repair and remodeling[J].Pharmacol Res,2008,58(2):148-151.
  • 10Urao N,Okigaki M,Yamada H,et al.Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia[J].Circ Res,2006,98(11):1405-1413.

二级参考文献14

  • 1李春蕊,张晶,刘文励,张木勋.罗格列酮对实验性2型糖尿病合并高脂血症大鼠骨骼肌组织IRS-1及GLUT4表达的调节[J].中国病理生理杂志,2007,23(5):900-903. 被引量:6
  • 2Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis [ J ]. Science, 1997, 275(5302): 964-967.
  • 3Lin Y, Weisdorf D J, Solovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood [J]. J Clin Invest, 2000, 105(1) : 71 -77.
  • 4Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood [ J ]. Blood, 2004,104 (9) :2752 - 2760.
  • 5Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis [ J ]. Arterioscler Thromb Vasc Biol, 2004,24(2) :288 -293.
  • 6Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures[J]. Circulation, 2002, 106(22): 2781 - 2786.
  • 7Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor [ J ]. Cardiovasc Res, 2003, 59(4): 824-833.
  • 8Schnabel R, Blankenberg S, Lubos E, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease [ J ]. Circ Res, 2005,97(5) :e53 - e59.
  • 9Sydow K, Munzel T. ADMA and oxidative stress [ J ]. Atheroscler Suppl, 2003, 4(4) :41 - 51.
  • 10Wang CH, Ciliberti N, Li SH, et ai. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage a new paradigm in glitazone pleiotropy[ J]. Circulation, 2004, 109( 11 ) : 1392 - 1400.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部